Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × Bendamustine Hydrochloride × Clear all

NCT04217317 2025-05-02

CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

Phase 2 Terminated

6 enrolled 13 charts

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell

NCT02424045 2018-09-06

Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma

Phase 2 Completed

Lymphoma, T-Cell

NCT00959686 2013-02-12

BENTLY

Phase 2 Completed

Lymphoma, T-Cell